RESULTS	Fasting plasma glucose and HbA1c levels were 209 + / - 31 mg/dL and 12.3 + / - 2.1 % , respectively , before initiation of glipizide , and did not significantly change following therapy ( fasting plasma glucose , 211 + / - 34 mg/dL ; HbA1c , 11.7 + / - 1.8 % ) .\